Dr. Moshe Neuman, founder & CEO of B.R.D, was selected as a regulatory consultant to the SPARK Project of Stanford University, global network extension in Israel at the Tel-Aviv University. http://spark-telaviv.tau.ac.il/
In front of a large crowd of audiences, and in the presence and participation of the top of the Department of Clinical Trials of the Ministry of Health in Israel, Dr. Neuman, B.R.D CEO, chaired the 5th Annual Israeli National Clinical Trial Congress and addressed the opening lecture “How GCP Revision 2, as well as …
Dr. Neuman, CEO of B.R.D – Biomedical Research Design, will chair the 5th National Conference on Clinical Research in Israel – I invite you to come and to be exposed to the upcoming changes in the regulatory landscape in GCP Guidelines affecting clinical trials design, conduct and management. I Guarantee you a Fascinating Scientific Program …
The 5th National Conference on Clinical Research in Israel 04.02.2019 Read More »
B.R.D CRO team is happy to take part at the BioMed 2015 exibition (Boot 192). We are happy to invite you to a in person, face-to-face meeting with B.R.D CEO and the CRO team to discuss your needs and expose you to our professional clinical development services.
Dr. Neuman, CEO of BRD, was asked to attend the investigator’s meeting at Mass General Hospital in Boston, US to present the experience gained by BRD CRO from conducting 2 stem cell trials in ALS patients in Israel at the opening of the Brainstorm trial in the United States.
“I thank the organizers for their invitation and the honor given to me, to chair the 1st National Conference for Clinical Research in Israel. This is an excellent, ideal opportunity for extended communication between researchers, sponsors and all other CRO and clinical sites personnel involved in clinical trials as well as to meet the regulators …
More than 24 planed business and consultation meetings were held during the four exhibition days of the at theLife Science Industry Event exhibition. B.R.D CRO team focused on presenting unique solutions to start-up companies seeking to lead their development project to a Proof of Concept (POC) clinical trial in humans.
B.R.D will take part in the annual event for the life sciences industries in Israel. You are welcome to meet us for an introductory or a consultation meeting at the exhibition.
More than 250 CRC and research nurses participated at the 1st Annual Israeli Conference for Clinical Trial Coordinators and Research nurses at the Medical Centers and Community Outpatient Clinics Conference today. Dr. Neuman addressed the Opening lecture “The CRC a key figure, essential to the success of the clinical research” and guided the experts panel …
Dr. Neuman, B.R.D CEO was invited by Abbvie Israel to join and participate in the thinking teams’ discussion on innovation in healthcare products development, held at the TEDMED Jerusalem 2014 event that took place during the month of September at the Jerusalem Theater.
